This session will review foundational principles of cardiovascular pharmacology and include both new medications and updated indications for cardiovascular medications Discussion will focus on medications used in the treatment of heart failure, coronary artery disease, atrial fibrillation and deep vein thrombosis.
Credits: 1.50 contact hours; 1.50 are pharmacology
After taking part in this educational activity, participants should be better able to:-Discuss mechanism of action, indication and adverse effects of 3 newer cardiac medications
-Describe new cardiovascular indications for currently available medications
-Describe implications for prescribing antiarrhythmic medications for atrial fibrillation
Midge T. Bowers, DNP, FNP-BC, AACC, FAANP, FAAN
Duke University School of Nursing Associate Professor and Duke Department of Medicine, Division of Cardiology Nurse Practitioner
Midge Bowers is an Associate Professor and Lead Faculty for the cardiovascular specialty at Duke University School of Nursing in Durham, NC. She holds a secondary appointment in the Department of Medicine as a nurse practitioner and is a faculty consultant at the School of Medicine. Dr. Bowers earned her BSN from Binghamton University, her MSN as a Clinical Nurse Specialist in critical care at Duke University School of Nursing, and completed a Post-Master’s Certificate as a Family Nurse Practitioner at Duke. Subsequently, she joined the faculty in 1999. She earned the Doctor of Nursing Practice degree from the University of Colorado-Denver. Her clinical practice focuses on patients with heart failure and her scholarly work focused on the care of patients with cardiovascular diseases. She is a fellow in the American Association of Nurse Practitioners and the American Academy of Nursing. She has presented on the national and international stage and has over 35 publications.
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
Contributing faculty, Margaret T. Bowers, DNP, FNP-BC, AACC, FAANP, FAAN have disclosed no relevant financial relationships.
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There is no commercial support for this activity.
|Access Date||Quiz Result||Score||Actions|